<DOC>
	<DOCNO>NCT02869672</DOCNO>
	<brief_summary>This study evaluate safety immunogenicity ACYW135 Meningococcal Polysaccharide Vaccine population age 2-50 year old . Subjects divide 3 group accord age , receive test vaccine control vaccine proportion 1:1 randomly . Each age group 400 subject , 1200 total .</brief_summary>
	<brief_title>Safety Immunogenicity Study ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>With subject ( guardian 's ) inform consent sign informed consent ; The history , physical examination clinical judgement determine healthy accordance vaccination age product ; The Subject guardian could comply clinical study protocol ; Have inoculate Meningococcal vaccine past six month A + C meningococcal polysaccharide vaccine past two year ; Have inoculate preventive biological product ; Axillary temperature≤37.0 ℃ . Children history Neisseria meningitis ; Had allergies serious adverse reaction previous vaccination , allergy , urticaria , dyspnea , edema , abdominal pain , etc ; Had immune inhibitor therapy cytotoxic therapy , inhale corticosteroid past 6 month ( include allergic rhinitis corticosteroid aerosol therapy , patient acute non concurrent dermatitis surface corticosteroid therapy ) ; Have accept blood product past 3 month ; Have inoculate research drug vaccine past month ; Have inoculate attenuate live vaccine past 14 day ; Have inoculate subunit inactivated vaccine past 7 day ; Had acute illness , need systemic application antibiotic antiviral treatment past 7 day ; Had fever past 3 day ( axillary temperature≥38.0℃ ) ; Have diagnose abnormal coagulation function ( lack coagulation factor , coagulation disorder abnormal blood platelet ) , obvious bruise coagulation disorder physician diagnosis ; Had history thyroid resection need treatment thyroid diseases past 12 month ; Asplenia , functional asplenia asplenia splenectomy situation ; Had epilepsy , convulsion , encephalopathy , mental illness family history ; Suffering serious chronic disease ( Down 's syndrome , diabetes , sickle cell anemia , neurological disorder GuillainBarre syndrome ) ; Suffering know suspected concurrent disease include : respiratory disease , acute chronic infection activity , child 's mother subject HIV infection , cardiovascular disease , high blood pressure , cancer treatment period , skin disease ; The female pregnant lactation period plan become pregnant trial . The subject factor suitable participate clinical trial accord researcher 's judgment .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>safety</keyword>
	<keyword>immunogenicity</keyword>
	<keyword>vaccine</keyword>
</DOC>